Mark Read dismisses the notion that there was a “pull forward” in investments in Q1 but acknowledges tariffs could hit some ...

Merck KGaA’s long courtship of SpringWorks Therapeutics has come to fruition as the German drugmaker has bought out the ...

Pfizer CEO Dr. Albert Bourla and Manas AI co-founder Reid Hoffman were among those discussing how health shapes the global ...

These eight upstart consulting firms are specialized and have an AI-first philosophy, helping them compete with established ...

Jonathan Rockoff is the Health Business editor at The Wall Street Journal, managing a team that reports on pharmaceutical and biotechnology companies, health insurers and hospitals. During the ...

Nona Biosciences, a global biotechnology company providing integrated solutions from "Idea to IND" (I to ITM), today announced that its partner, Pfizer, has presented preclinical data on PF-08052666 ...

When the rollback was announced shortly after Trump took action against DEI programs in the federal government by executive ...

The technology is genuinely useful for scientific discovery, but its applications are less dramatic than you might think.

The pharma executive also warned that cuts in government funding, along with reduced private sector investment, increases the ...

Perhaps no industry is as reliant on grant-funded university research as is bioscience, the companies that develop ...

Bojan Pancevski is The Wall Street Journal’s chief European political correspondent, covering European and global affairs. He ...

Chemicals firms Dow and LyondellBasell are the biggest dividend payers in the S&P 500. Other fat divided payouts include ...